Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Strategic Implications If validated in prospective randomized trials, GLP-1 receptor agonists could: Represent an adjunctive strategy in obesity-associated asthma Expand the therapeutic footprint of GLP-1s beyond metabolic disease Influence treatment guidelines in high-BMI asthma populations Given the rapid adoption of GLP-1 therapies globally, further investigation into respiratory benefits could have significant clinical and commercial implications
If someone reading this is taking GLP1 medication, don't listen to this guy
Some Patients Stop After Reaching Their Goals Another possible explanation is that some individuals discontinue treatment after achieving meaningful weight loss or improved blood sugar control
Superior Research Profile
As the cartilage degenerates, it eventually causes the underlying bones to be exposed and rub against each other, causing a lot of pain
US$ 27.50
US$ 23.02
US$ 26.81
